1. Report Introduction 2. Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Overview 3. Pipeline Therapeutics • An Overview of Pipeline Products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) 4. Comparative Analysis 5. Products in Clinical Stage 5.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 6. Products in Pre-Clinical and Discovery Stage 6.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities 7. Therapeutic Assessment • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type 8. Inactive Products 8.1 Drug Name : Company Name • Product Description • Research and Development • Product Development Activities Appendix Report Methodology Consulting Services Disclaimer About DelveInsight

Table 1: Total Products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Table 2: Products in Clinical Stage Table 3: Products in Non-clinical Stage Table 4: Assessment by Route of Administration Table 5: Assessment by Stage and Route of Administration Table 6: Assessment by Molecule Type Table 7: Assessment by Stage and Molecule Type Table 8: Inactive Products Figure 1: Total Products for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Figure 2: Products in Clinical Stage Figure 3: Products in Non-clinical Stage Figure 4: Assessment by Route of Administration Figure 5: Assessment by Stage and Route of Administration Figure 6: Assessment by Molecule Type Figure 7: Assessment by Stage and Molecule Type Figure 8: Inactive Products

AnGes MG Inc AstraZeneca Plc Athera Biotechnologies AB Athersys Inc Bayer AG Betagenon AB BiogenCell Ltd CardioVascular BioTherapeutics Inc Celgene Corp Diffusion Pharmaceuticals Inc Foresee Pharmaceuticals LLC Hemostemix Ltd ID Pharma Co Ltd Juventas Therapeutics Inc LipimetiX Development Inc miRagen Therapeutics Inc Novartis AG Nuo Therapeutics Inc Proteon Therapeutics Inc Recardio GmbH Resverlogix Corp Sigma-Tau SpA & list continues...